Fatigue  ||| S:0 E:8 ||| NNP
and  ||| S:8 E:12 ||| CC
exercise  ||| S:12 E:21 ||| NN
intolerance  ||| S:21 E:33 ||| NN
in  ||| S:33 E:36 ||| IN
mitochondrial  ||| S:36 E:50 ||| JJ
diseases ||| S:50 E:58 ||| NNS
.  ||| S:58 E:60 ||| .
Literature  ||| S:60 E:71 ||| NN
revision  ||| S:71 E:80 ||| NN
and  ||| S:80 E:84 ||| CC
experience  ||| S:84 E:95 ||| NN
of  ||| S:95 E:98 ||| IN
the  ||| S:98 E:102 ||| DT
Italian  ||| S:102 E:110 ||| JJ
Network  ||| S:110 E:118 ||| NNP
of  ||| S:118 E:121 ||| IN
mitochondrial  ||| S:121 E:135 ||| JJ
diseases  ||| S:135 E:144 ||| NNS
Fatigue  ||| S:144 E:152 ||| NNP
and  ||| S:152 E:156 ||| CC
exercise  ||| S:156 E:165 ||| NN
intolerance  ||| S:165 E:177 ||| NNS
are  ||| S:177 E:181 ||| VBP
common  ||| S:181 E:188 ||| JJ
symptoms  ||| S:188 E:197 ||| NNS
of  ||| S:197 E:200 ||| IN
mitochondrial  ||| S:200 E:214 ||| JJ
diseases ||| S:214 E:222 ||| NNS
,  ||| S:222 E:224 ||| ,
but  ||| S:224 E:228 ||| CC
difficult  ||| S:228 E:238 ||| JJ
to  ||| S:238 E:241 ||| TO
be  ||| S:241 E:244 ||| VB
clinically  ||| S:244 E:255 ||| RB
assessed ||| S:255 E:263 ||| VBN
.  ||| S:263 E:265 ||| .
New  ||| S:265 E:269 ||| JJ
methods  ||| S:269 E:277 ||| NNS
to  ||| S:277 E:280 ||| TO
quantify  ||| S:280 E:289 ||| VB
these  ||| S:289 E:295 ||| DT
rather  ||| S:295 E:302 ||| RB
common  ||| S:302 E:309 ||| JJ
complaints  ||| S:309 E:320 ||| NNS
are  ||| S:320 E:324 ||| VBP
strongly  ||| S:324 E:333 ||| RB
needed  ||| S:333 E:340 ||| VBN
in  ||| S:340 E:343 ||| IN
the  ||| S:343 E:347 ||| DT
clinical  ||| S:347 E:356 ||| JJ
practice ||| S:356 E:364 ||| NN
.  ||| S:364 E:366 ||| .
Coenzyme  ||| S:366 E:375 ||| NNP
Q10  ||| S:375 E:379 ||| NNP
administration  ||| S:379 E:394 ||| NN
and  ||| S:394 E:398 ||| CC
aerobic  ||| S:398 E:406 ||| JJ
exercise  ||| S:406 E:415 ||| NN
may  ||| S:415 E:419 ||| MD
improve  ||| S:419 E:427 ||| VB
exercise  ||| S:427 E:436 ||| NN
intolerance ||| S:436 E:447 ||| NN
,  ||| S:447 E:449 ||| ,
but  ||| S:449 E:453 ||| CC
more  ||| S:453 E:458 ||| RBR
definite  ||| S:458 E:467 ||| JJ
studies  ||| S:467 E:475 ||| NNS
are  ||| S:475 E:479 ||| VBP
still  ||| S:479 E:485 ||| RB
pending ||| S:485 E:492 ||| VBG
.  ||| S:492 E:494 ||| .
Herein ||| S:494 E:500 ||| NNP
,  ||| S:500 E:502 ||| ,
we  ||| S:502 E:505 ||| PRP
have  ||| S:505 E:510 ||| VBP
revised  ||| S:510 E:518 ||| VBN
how  ||| S:518 E:522 ||| WRB
to  ||| S:522 E:525 ||| TO
measure  ||| S:525 E:533 ||| VB
and  ||| S:533 E:537 ||| CC
how  ||| S:537 E:541 ||| WRB
to  ||| S:541 E:544 ||| TO
treat  ||| S:544 E:550 ||| VB
these  ||| S:550 E:556 ||| DT
symptoms  ||| S:556 E:565 ||| NNS
of  ||| S:565 E:568 ||| IN
mitochondrial  ||| S:568 E:582 ||| JJ
patients ||| S:582 E:590 ||| NNS
.  ||| S:590 E:592 ||| .
Subsequently ||| S:592 E:604 ||| RB
,  ||| S:604 E:606 ||| ,
we  ||| S:606 E:609 ||| PRP
reviewed  ||| S:609 E:618 ||| VBD
the  ||| S:618 E:622 ||| DT
clinical  ||| S:622 E:631 ||| JJ
data  ||| S:631 E:636 ||| NNS
of  ||| S:636 E:639 ||| IN
the  ||| S:639 E:643 ||| DT
1164  ||| S:643 E:648 ||| CD
confirmed  ||| S:648 E:658 ||| VBD
mitochondrial  ||| S:658 E:672 ||| JJ
patients  ||| S:672 E:681 ||| NNS
present  ||| S:681 E:689 ||| JJ
in  ||| S:689 E:692 ||| IN
the  ||| S:692 E:696 ||| DT
Italian  ||| S:696 E:704 ||| JJ
nation-wide  ||| S:704 E:716 ||| JJ
database  ||| S:716 E:725 ||| NN
of  ||| S:725 E:728 ||| IN
mitochondrial  ||| S:728 E:742 ||| JJ
disease ||| S:742 E:749 ||| NN
,  ||| S:749 E:751 ||| ,
with  ||| S:751 E:756 ||| IN
special  ||| S:756 E:764 ||| JJ
regard  ||| S:764 E:771 ||| NN
to  ||| S:771 E:774 ||| TO
exercise  ||| S:774 E:783 ||| VB
intolerance ||| S:783 E:794 ||| NN
.  ||| S:794 E:796 ||| .
We  ||| S:796 E:799 ||| PRP
observed  ||| S:799 E:808 ||| VBD
that  ||| S:808 E:813 ||| IN
more  ||| S:813 E:818 ||| JJR
of  ||| S:818 E:821 ||| IN
20 ||| S:821 E:823 ||| CD
%  ||| S:823 E:825 ||| NN
of  ||| S:825 E:828 ||| IN
mitochondrial  ||| S:828 E:842 ||| JJ
patients  ||| S:842 E:851 ||| NNS
complain  ||| S:851 E:860 ||| VBP
of  ||| S:860 E:863 ||| IN
exercise  ||| S:863 E:872 ||| NN
intolerance ||| S:872 E:883 ||| NN
.  ||| S:883 E:885 ||| .
This  ||| S:885 E:890 ||| DT
symptom  ||| S:890 E:898 ||| NN
seems  ||| S:898 E:904 ||| VBZ
to  ||| S:904 E:907 ||| TO
be  ||| S:907 E:910 ||| VB
frequently  ||| S:910 E:921 ||| RB
associated  ||| S:921 E:932 ||| VBN
with  ||| S:932 E:937 ||| IN
specific  ||| S:937 E:946 ||| JJ
patient  ||| S:946 E:954 ||| NN
groups  ||| S:954 E:961 ||| NNS
and ||| S:961 E:964 ||| CC
/ ||| S:964 E:965 ||| NNP
or  ||| S:965 E:968 ||| CC
genotypes ||| S:968 E:977 ||| NN
.  ||| S:977 E:979 ||| .
Ragged  ||| S:979 E:986 ||| JJ
red  ||| S:986 E:990 ||| JJ
fibers  ||| S:990 E:997 ||| NNS
and  ||| S:997 E:1001 ||| CC
COX-negative  ||| S:1001 E:1014 ||| JJ
fibers  ||| S:1014 E:1021 ||| NNS
are  ||| S:1021 E:1025 ||| VBP
more  ||| S:1025 E:1030 ||| RBR
often  ||| S:1030 E:1036 ||| RB
present  ||| S:1036 E:1044 ||| VB
in  ||| S:1044 E:1047 ||| IN
subjects  ||| S:1047 E:1056 ||| NNS
with  ||| S:1056 E:1061 ||| IN
exercise  ||| S:1061 E:1070 ||| NN
intolerance ||| S:1070 E:1081 ||| NN
,  ||| S:1081 E:1083 ||| ,
whereas  ||| S:1083 E:1091 ||| IN
lactate  ||| S:1091 E:1099 ||| JJ
levels  ||| S:1099 E:1106 ||| NNS
could  ||| S:1106 E:1112 ||| MD
not  ||| S:1112 E:1116 ||| RB
predict  ||| S:1116 E:1124 ||| VB
this  ||| S:1124 E:1129 ||| DT
symptom ||| S:1129 E:1136 ||| NN
.  ||| S:1136 E:1138 ||| .
Multicenter  ||| S:1138 E:1150 ||| JJ
efforts  ||| S:1150 E:1158 ||| NNS
are  ||| S:1158 E:1162 ||| VBP
strongly  ||| S:1162 E:1171 ||| RB
needed  ||| S:1171 E:1178 ||| VBN
for  ||| S:1178 E:1182 ||| IN
rare  ||| S:1182 E:1187 ||| JJ
disorders  ||| S:1187 E:1197 ||| NNS
such  ||| S:1197 E:1202 ||| JJ
as  ||| S:1202 E:1205 ||| IN
mitochondrial  ||| S:1205 E:1219 ||| JJ
diseases ||| S:1219 E:1227 ||| NNS
,  ||| S:1227 E:1229 ||| ,
and  ||| S:1229 E:1233 ||| CC
may  ||| S:1233 E:1237 ||| MD
represent  ||| S:1237 E:1247 ||| VB
the  ||| S:1247 E:1251 ||| DT
basis  ||| S:1251 E:1257 ||| NN
for  ||| S:1257 E:1261 ||| IN
more  ||| S:1261 E:1266 ||| RBR
rigorous  ||| S:1266 E:1275 ||| JJ
longitudinal  ||| S:1275 E:1288 ||| JJ
studies ||| S:1288 E:1295 ||| NNS
.  ||| S:1295 E:1297 ||| .
